Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 582 participants.

Also called NCT01519674

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 582 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01519674
  • EudraCT 2011-004930-33
Other papers using this trial's data
  • The study of once- and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin-The Sit2Mix trial Primary care diabetes, 2015-10 DOI, PubMed 25488587

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Argentina, Australia, Brazil, Greece, India, Malaysia, Portugal, South Korea, Thailand, Türkiye (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01519674. Randomized; no masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2013-10 (actual). Results posted on 2014-11-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin
Acronym
SIT2MIX
Condition
Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
biphasic insulin aspart 30
Intervention (Drug)
biphasic insulin aspart 30
Intervention (Drug)
sitagliptin
Intervention (Drug)
metformin
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct01519674
Content hash
2b1051eb3dc283b32cb5fcec3c10c9ace3a27d5a85191578b72dda94d059da32